Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND1N) Q4 2025 Earnings Report

0 Followers

MX:ASND1N Q4 2025 EPS Results

Actual EPS
-MXN 11.25
Consensus EPS
-MXN 1.64
Beat/Miss
Missed by -MXN 9.61
One Year Ago EPS
-MXN 13.09

MX:ASND1N Q4 2025 Revenue Results

Actual Revenue
MXN 5.35B
Expected Revenue
MXN 5.02B
Beat/Miss
Beat by +MXN 322.89M
YoY Revenue Growth
+55.28%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/11/2026
Time
After Close
Conference Call
Wednesday, February 11, 2026
MX:ASND1N Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

MX:ASND1N Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ASND1N Earnings History

MX:ASND1N earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 17, 20272026 (Q4)33.13--11.25――
Nov 12, 20262026 (Q3)16.2622.09-20.45208.00% (+42.54)
Aug 13, 20262026 (Q2)30.6257.88-16.77445.12% (+74.65)
May 07, 20262026 (Q1)―199.41-32.31717.09% (+231.72)
Feb 11, 20262025 (Q4)-1.64-11.25-13.0914.06% (+1.84)
Nov 12, 20252025 (Q3)-4.99-20.45-35.1841.86% (+14.73)
Aug 07, 20252025 (Q2)-26.30-16.77-39.0657.07% (+22.29)
May 01, 20252025 (Q1)-30.00-32.31-47.0431.30% (+14.73)
Feb 12, 20252024 (Q4)-20.12-13.09-31.558.44% (+18.41)
Nov 14, 20242024 (Q3)-32.01-35.18-55.0236.06% (+19.84)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed